CD19 and B-cell chronic lymphocytic leukemia: In Phase 3, a proportion of the spleen-residing CD5+CD19+ cells have undergone multiple cell divisions (≥ 6) as indicated by complete absence of CFSE as measured by FC, with the degree of CLL B-cell replication varying among patients.